{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:02:02Z","timestamp":1791889322948,"version":"4.3.4"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.ejogrb.2013.11.009","type":"journal-article","created":{"date-parts":[[2013,11,20]],"date-time":"2013-11-20T22:02:27Z","timestamp":1384984947000},"page":"13-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Fertility after breast cancer treatment"],"prefix":"10.1016","volume":"173","author":[{"given":"Miro","family":"Kasum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidija","family":"Beketi\u0107-Ore\u0161kovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parvin F.","family":"Peddi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Slavko","family":"Ore\u0161kovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca H.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2013.11.009_bib0005","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10549-012-2031-7","article-title":"Breast cancer incidence trends in European women aged 20\u201339 years at diagnosis","volume":"134","author":"Merlo","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0010","first-page":"309","article-title":"Incidence of breast cancer with distant involvement among women in the United States, 1976 to 2009","volume":"27","author":"Johnson","year":"2013","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0015","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0002-9610(03)00272-1","article-title":"An increased risk of breast disease after delayed parity","volume":"185","author":"Lee","year":"2003","journal-title":"Am J Surg"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0020","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.fertnstert.2011.01.169","article-title":"Determinants of access to fertility preservation in women with breast cancer","volume":"95","author":"Lee","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0025","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1093\/annonc\/mdf227","article-title":"Predictive factors for local recurrence in 2006 patients with surgically resected small breast cancer","volume":"13","author":"Arriagada","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0030","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1159\/000227622","article-title":"Pregnancy and offspring after the appearance of breast cancer","volume":"53","author":"Malamos","year":"1996","journal-title":"Oncology"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0035","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0889-8529(05)70051-7","article-title":"Premature ovarian failure","volume":"27","author":"Kalantaridou","year":"1998","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0040","first-page":"486s","article-title":"Adjuvant hormonal therapy for premenopausal women with breast cancer","volume":"9","author":"Emens","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0045","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1055\/s-0029-1241059","article-title":"Fertility preservation for breast cancer patients","volume":"27","author":"Oktem","year":"2009","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0050","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1200\/JCO.2001.19.6.1688","article-title":"Difference on risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials","volume":"19","author":"Voogd","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0055","doi-asserted-by":"crossref","first-page":"3817","DOI":"10.1200\/JCO.2001.19.18.3817","article-title":"Meeting highlights: international consensus panel on the treatment of primary breast cancer. Seventh international conference on adjuvant therapy of primary breast cancer","volume":"19","author":"Goldhirsch","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0060","first-page":"131","article-title":"Pregnancy after breast conserving surgery and radiation therapy for breast cancer","volume":"16","author":"Dow","year":"1994","journal-title":"Inst Monog"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0065","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/1097-0142(19940415)73:8<2175::AID-CNCR2820730823>3.0.CO;2-#","article-title":"Pregnancy and lactation after breast conserving therapy for early stage breast cancer","volume":"73","author":"Higgins","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0070","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1177\/107327480200900603","article-title":"Chemotherapy-induced amenorrhea and fertility in women undergoing adjuvant treatment for breast cancer","volume":"9","author":"Minton","year":"2002","journal-title":"Cancer Control"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0075","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/oxfordjournals.aje.a009995","article-title":"Early menopause and infertility in females after treatment for childhood cancer diagnosed in 1964\u20131988 in Ontario","volume":"150","author":"Chiarelli","year":"1999","journal-title":"Can Am J Epidemiol"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0080","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/(SICI)1097-0142(19970401)79:7<1271::AID-CNCR1>3.0.CO;2-K","article-title":"Childbearing issues in breast carcinoma survivors","volume":"19","author":"Surbone","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0085","first-page":"560","article-title":"Ovarian rescue\/protection from chemotherapeutic agents","volume":"8","author":"Blumenfeld","year":"2001","journal-title":"J Soc Gynecol Investig"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0090","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/1097-0142(19900215)65:4<847::AID-CNCR2820650402>3.0.CO;2-A","article-title":"Pregnancy and offspring after adjuvant chemotherapy in breast cancer patients","volume":"65","author":"Sutton","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0095","first-page":"337","article-title":"Antineoplastic agents and pregnancy","volume":"16","author":"Doll","year":"1989","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0100","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/cncr.22081","article-title":"Treatment in pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero","volume":"107","author":"Hahn","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0105","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/annonc\/mdh009","article-title":"Anthracyclines during pregnancy: embryo-fetal outcome in 160 patients","volume":"15","author":"Germann","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0110","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S1470-2045(06)71014-2","article-title":"Anhydramnios associated with administration of trastuzumab and paclitaxel for metastatic breast cancer during pregnancy","volume":"8","author":"Bader","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0115","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/1097-0142(19870901)60:5<1143::AID-CNCR2820600537>3.0.CO;2-E","article-title":"Pregnancy outcome in cancer patients","volume":"60","author":"Mulvihill","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0120","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/cncr.11929","article-title":"Effects of pregnancy after treatment for breast carcinoma on survival and risk of recurrence","volume":"100","author":"Blakely","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0125","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0960-9776(98)90025-X","article-title":"Contraceptive use by women receiving chemotherapy for breast cancer","volume":"7","author":"Valle","year":"1998","journal-title":"Breast"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0130","first-page":"30","article-title":"Adjuvant treatment of premenopausal breast cancer with zoladex and tamoxifen","volume":"57","author":"Baum","year":"1999","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0135","first-page":"38a","article-title":"Is the addition of adjuvant chemotherapy always necessary in node negative (N\u2212) pre\/perimenopausal breast cancer patients who receive goserelin","volume":"21","author":"Castiglione-Gertsch","year":"2002","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0140","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/j.ejca.2004.04.019","article-title":"LH\u2013RH agonists offer very good protection against the adverse gynaecological effects induced by tamoxifen","volume":"40","author":"Berliere","year":"2004","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0145","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/AOG.0b013e31827374e2","article-title":"Gonadatrophin suppression to prevent chemotherapy-induced ovarian damage: a randomized controlled trial","volume":"121","author":"Elgidy","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0150","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/oxfordjournals.annonc.a057718","article-title":"The magnitude of endocrine effects of adjuvant chemotherapy for premenopausal breast cancer patients. The International Breast Cancer Study Group","volume":"1","author":"Goldhirsch","year":"1990","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0155","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S0959-8049(97)10036-3","article-title":"Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the International Breast Cancer Study Group (IBCSG) Trial VI","volume":"34","author":"Pagani","year":"1998","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0160","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1093\/jnci\/djg119","article-title":"Adjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trial","volume":"95","author":"International Breast Cancer Study Group (IBCSG)","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0165","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/bjc.1991.177","article-title":"Prognostic role of amenorrhea induced by adjuvant chemotherapy in premenopausal patients with early breast cancer","volume":"63","author":"Bianco","year":"1991","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0170","doi-asserted-by":"crossref","first-page":"4628","DOI":"10.1200\/JCO.2002.05.042","article-title":"Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association Study","volume":"20","author":"Jonat","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0175","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/01.coc.0000251398.57630.4f","article-title":"The rates of chemotherapy-induced amenorrhea in patients treated with adjuvant doxorubicin and cyclophosphamide followed by a taxane","volume":"30","author":"Tham","year":"2007","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0180","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1093\/annonc\/mdl107","article-title":"Complete hormonal blockade versus epirubicin-based chemotherapy in premenopausal, one to three node-positive, and hormone-receptor positive, early breast cancer patients: 7-year follow-up results of French Adjuvant Study Group 06 randomised trial","volume":"17","author":"Roch\u00e9","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0185","first-page":"155A","article-title":"The effects of breast cancer chemotherapy on menstrual function","volume":"17","author":"Luporsi","year":"1998","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0190","first-page":"S30","article-title":"Role of chemo-induced amenorrhea in premenopausal, node-positive, operable breast cancer patients: 9-year follow-up results of French Adjuvant Study Group data base","volume":"82","author":"Borde","year":"2003","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0195","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1200\/JCO.2010.29.7689","article-title":"Menstrual history and quality-of-life outcomes in women with node-positive breast cancer treated with adjuvant therapy on the NSABP B-30 trial","volume":"29","author":"Ganz","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0200","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1002\/cncr.21385","article-title":"Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane","volume":"104","author":"Fornier","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0205","first-page":"S105","article-title":"Chemotherapy-induced amenorrhea (CIA) in patients treated with adjuvant CEF\/CMF or EC\/docetaxel: analysis from a phase III randomized EC\/Doc trial","volume":"94","author":"Samuelkutty","year":"2005","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0210","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1056\/NEJMoa043681","article-title":"Adjuvant docetaxel for node-positive breast cancer","volume":"352","author":"Martin","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0215","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0015-0282(16)55160-7","article-title":"Successful in vitro fertilization and embryo transfer after treatment of invasive carcinoma of the breast","volume":"58","author":"El Hussein","year":"1992","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0220","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1096\/fj.01-0498fje","article-title":"The estrogen-regulated protein TFF1, stimulates migration of human breast cancer cells","volume":"16","author":"Prest","year":"2002","journal-title":"FASSEB J"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0225","first-page":"855","article-title":"Tamoxifen treatment and gynecologic side effects: a review","volume":"97","author":"Mourits","year":"2000","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0230","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/humrep\/deg045","article-title":"Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen","volume":"18","author":"Oktay","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0235","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1200\/JCO.2005.05.037","article-title":"Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation","volume":"23","author":"Oktay","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0240","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.fertnstert.2012.09.022","article-title":"Ovarian stimulation and fertility preservation with the use of aromatase inhibitors in women with breast cancer","volume":"98","author":"Reddy","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0245","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.gyobfe.2011.07.011","article-title":"Oocyte\/embryo cryopreservation before chemotherapy for breast cancer","volume":"39","author":"Decanter","year":"2011","journal-title":"Gynecol Obstet Fertil"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0250","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(04)17222-X","article-title":"Livebirth after orthotopic transplantation of cryopreserved ovarian tissue","volume":"364","author":"Donnez","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0255","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.fertnstert.2013.03.030","article-title":"Restoration of ovarian activity and pregnancy after transplantation of cryopreserved ovarian tissue: a review of 60 cases of reimplantation","volume":"99","author":"Donnez","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0260","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.fertnstert.2008.10.006","article-title":"Ovarian cryopreservation and transplantation for fertility preservation for medical indications: report of an ongoing experience","volume":"93","author":"Oktay","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0265","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/j.fertnstert.2013.02.004","article-title":"Five years\u2019 experience using oocyte vitrification to preserve fertility for medical and nonmedical indications","volume":"99","author":"Garcia-Velasco","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0270","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s10815-013-0024-z","article-title":"Fifteen year follow-up of embryos cryopreserved in cancer patients for fertility preservation","volume":"30","author":"Barcroft","year":"2013","journal-title":"J Assist Reprod Gen"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0275","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.rbmo.2010.01.012","article-title":"In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation","volume":"20","author":"Oktay","year":"2010","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0280","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.rbmo.2010.05.003","article-title":"Fertility preservation for breast-cancer patients using IVM followed by oocyte or embryo vitrification","volume":"21","author":"Shalom-Paz","year":"2010","journal-title":"Reprod Med Online"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0285","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.fertnstert.2013.01.141","article-title":"In vitro maturation of human immature oocytes for fertility preservation","volume":"99","author":"Chian","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0290","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.fertnstert.2013.03.027","article-title":"Risk of transferring malignant cells with transplanted frozen-thawed ovarian tissue","volume":"99","author":"Dolmans","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0295","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1634\/theoncologist.2012-0236","article-title":"Fertility preservation and pregnancy in women with and without BRCA mutation-positive breast cancer","volume":"17","author":"Rodriguez-Wallberg","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.ejogrb.2013.11.009_bib0300","doi-asserted-by":"crossref","first-page":"172ra21","DOI":"10.1126\/scitranslmed.3004925","article-title":"Impairment of BRCA 1-related DNA double strand break repair leads to ovarian aging in mice and humans","volume":"5","author":"Titus","year":"2013","journal-title":"Sci Transl Med"}],"container-title":["European Journal of Obstetrics &amp; Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211513005654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211513005654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T05:29:20Z","timestamp":1759555760000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211513005654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":60,"alternative-id":["S0301211513005654"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2013.11.009","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fertility after breast cancer treatment","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2013.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}